List of publications

All the publications of the C3M teams.

Export in CSV
Hallucination Rates and Reference Accuracy of ChatGPT and Bard for Systematic Reviews: Comparative Analysis.

Authors Chelli M, Descamps J, Lavoué V, Trojani C, Azar M, Deckert M, Raynier JL, Clowez G, Boileau P, Ruetsch-Chelli C

Journal of medical Internet research May 2024

The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance.

Authors Diazzi S, Tartare-Deckert S, Deckert M

Oncogenesis Feb 2023

The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.

Authors Shoji KF, Bayet E, Leverrier-Penna S, Le Devedec D, Mallavialle A, Marionneau-Lambot S, Rambow F, Perret R, Joussaume A, Viel R, Fautrel A, Khammari A, Constantin B, Tartare-Deckert S, Penna A

EMBO reports Feb 2023

Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis.

Authors Ruetsch-Chelli C, Okuda DT, Rocher F, Tartare-Deckert S, Deckert M, Lebrun-Frenay C

Neurology and therapy Dec 2022

Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance.

Authors Popovic A, Tartare-Deckert S

Frontiers in oncology Sep 2022

The Stress-Responsive microRNA-34a Alters Insulin Signaling and Actions in Adipocytes through Induction of the Tyrosine Phosphatase PTP1B.

Authors Cornejo PJ, Vergoni B, Ohanna M, Angot B, Gonzalez T, Jager J, Tanti JF, Cormont M

Cells Aug 2022

Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis.

Authors Ohanna M, Biber P, Deckert M

Cancers Jul 2022

Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells.

Authors Rovera C, Berestjuk I, Lecacheur M, Tavernier C, Diazzi S, Pisano S, Irondelle M, Mallavialle A, Albrengues J, Gaggioli C, Girard CA, Passeron T, Deckert M, Tartare-Deckert S, Prod'homme V

Cancer research May 2022

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation.

Authors Sala M, Allain N, Moreau M, Jabouille A, Henriet E, Abou-Hammoud A, Uguen A, Di-Tommaso S, Dourthe C, Raymond AA, Dupuy JW, Gerard E, Dugot-Senant N, Rousseau B, Merlio JP, Pham-Ledart A, Vergier B, Tartare-Deckert S, Moreau V, Saltel F

Oncogene Mar 2022

Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma.

Authors Diazzi S, Baeri A, Fassy J, Lecacheur M, Marin-Bejar O, Girard CA, Lefevre L, Lacoux C, Irondelle M, Mounier C, Truchi M, Couralet M, Ohanna M, Carminati A, Berestjuk I, Larbret F, Gilot D, Vassaux G, Marine JC, Deckert M, Mari B, Tartare-Deckert S

EMBO molecular medicine Feb 2022